相关实验视频

Updated: Feb 28, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

通过下一代测序识别新型HLA-B*57:205等位基因的鉴定

Ruby J Siegel¹, Katrin Hacke¹, Rose M Ridgley¹

¹Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona, USA.

|February 27, 2026

概括

人类白细胞抗原 (HLA) B*57:205是一种新发现的等位基因. 它与常见的HLA-B*57:01:01:01有所不同,在Exon 1中单个核酸替代.

科学领域:

免疫遗传学免疫遗传学
分子生物学分子生物学
人类白细胞抗原 (HLA) 系统

背景情况:

HLA-B位点在免疫反应中起着至关重要的作用.
在HLA基因中的等位基因变异有助于各种免疫能力和疾病易感性.
特定的HLA-B等位基因与对病毒感染 (如HIV) 的差异控制有关.

研究的目的:

为了表征一种新的HLA-B等位基因,指定HLA-B*57:205.
为了确定HLA-B*57:205和一个特征很好的相关等位基因之间的特定遗传差异,HLA-B*57:01:01:01.

主要方法:

在HLA-B基因的核酸序列.
进行比较序列分析以识别变异.
遗传数据的生物信息分析.

主要成果:

HLA-B*57:205被确定为HLA-B*57家族中的一个独特的等位基因.
在HLA-B*57:205的Exon 1中检测到单个核酸替代,与HLA-B*57:01:01:01.1相比.
这种替代代表了这两个等位基因之间的唯一遗传差异.

结论:

HLA-B*57:205代表了HLA-B*57超型中的一种新的遗传变异.
在Exon 1中发现的核酸替代是HLA-B*57:205.的定义特征.
需要进一步的研究来调查这种新等位基因的潜在免疫学或临床影响.

关键词:

在 HLA-B*57:205 中.这是下一代测序.这是一个新型的HLA等位基因.

更多相关视频

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing

T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing

Published on: January 12, 2021

相关概念视频

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...